Orthocell Ltd (@OrthocellLtd) header
Orthocell Ltd (@OrthocellLtd) profile picture

Orthocell develops regenerative medicine solutions for bone, nerve and tendon repair, enabling surgeons to improve outcomes and restore patient mobility.

Perth, Western Australia
Joined April 2017
Photo by Orthocell Ltd (@OrthocellLtd)Photo by Orthocell Ltd (@OrthocellLtd)Photo by Orthocell Ltd (@OrthocellLtd)Photo by Orthocell Ltd (@OrthocellLtd)Photo by Orthocell Ltd (@OrthocellLtd)Photo by Orthocell Ltd (@OrthocellLtd)Photo by Orthocell Ltd (@OrthocellLtd)Photo by Orthocell Ltd (@OrthocellLtd)
Meet the faculty for the Orthocell lunch symposium at the American Association for Hand Surgery (@HandSurgeryAssn) AAHS/ASPN/ASRM combined 2027 Annual Meetings in Aventura, Florida. 🎓 Remplir™: From nerve repair to nerve regeneration 🗓️ Friday, January 29, 2027 🕧 12:30–2:00 PM ET ✍handsurgery.org/forms/2027/S… 👨‍⚕️ Harry Hoyen, MD | Advanced and emerging concepts in nerve repair. 👨‍⚕️ Michael Doarn, MD | The role of an epineurial substitute in non-transected nerve injuries. 👨‍⚕️ Ryan Schmucker, MD | Optimizing nerve repair and protection: clinical applications of an epineurial substitute across trauma and upper extremity decompression. 👨‍⚕️ Edward M. Kobraei, MD | Functional demands of nerve repair relating to my clinical experience with an epineurial substitute. 👨‍⚕️ Dr Alex O'Beirne | From nerve transfer for brachial plexus and spinal cord injuries to neuroma management: Clinical outcomes with an epineurial substitute. The session closes with a faculty case discussion and Q&A. If you are attending, we'd love to see you there. Visit us at booth 110, Majestic Ballroom & Foyer. #AAHS2027 #ASPN2027 #ASRM2027 #HandSurgery #PeripheralNerve #NerveRepair #SurgicalEducation
58
Register for Orthocell's Remplir™ Lab at @HandSurgeryAssn 2027 Annual Meeting in Aventura, Florida. 🎓 Nerve Repair Surgical Techniques with Remplir™ an Epineurial Substitute. 👨‍⚕️ Barth Riedel, MD 🗓️ Friday, January 28, 2027 | 2:30-4:30 PM ET 📌 JW Marriott Miami Turnberry Resort & Spa, Aventura, FL Explore advanced surgical techniques using an epineurial substitute that is easy to handle, elastic and conformable, promotes nerve glide and fully resorbs. If you're attending, we'd love to see you there. Limited places available. Reserve yours now 👉 handsurgery.org/forms/2027/S… #AAHS2027 #ASPN2027 #ASRM2027 #HandSurgery #PeripheralNerve #NerveRepair #SurgicalEducation
2
110
Orthocell Manufacturing Manager Adam Cias joined the panel session at the @AusBiotech International Conference 2026 on the Gold Coast last month: Built to compete: manufacturing as Australia’s strategic advantage. The panel examined how manufacturing now shapes investment decisions, commercialisation strategy, and the speed at which new therapies and technologies reach patients. Adam was joined on the panel by Karyn McIntosh, Katie Wood, Felicia Pradera, Prof Dr Ulrike Fiedler and Daniel Getts. They discussed how Australia can strengthen sovereign capability through a nationally connected manufacturing ecosystem, concentrating on the areas where the country can lead while staying part of global supply chains. Adam brought the perspective of a company that manufactures its own products at its headquarters in Perth and distributes them internationally. For Orthocell, owning our manufacturing supply chain means we can deliver high-quality products to patients globally. #AusBiotech #australianmedtech #australianbiotech #sovereignmanufacturing #australianmade
83
Orthocell’s Eimer Gordon and Hamish Thrum are at the 2026 Shoulder & Elbow Society of Australia (SESA) Biennial Conference in Geelong this week, 11–14 November. The team will be discussing our cell therapy programs, including OrthoATI™, our autologous tendon cell therapy for chronic tendon injuries. We will also be sharing information about our Remplir™, our epineurial substitute designed to support the repair and protection of peripheral nerves. If you’re at SESA you’ll find us at stand #36, next to Device Technologies (@devicetech), our Australian and New Zealand distribution partner for Remplir. OrthoATI™: orthocell.com/au/practitione… Remplir: orthocell.com/au/solutions/r… #SESA2026 #ShoulderSurgery #ElbowSurgery #PeripheralNerveSurgery #Orthopaedics
1
69
Orthocell was in Edinburgh last week for the British Society for Surgery of the Hand (@BSSHand) Autumn Scientific Meeting 2026. The meeting was held in conjunction with the American Society for Surgery of the Hand (@TheHandSociety), this year's guest society. The program brings together hand surgeons from the UK, US and around the world for discussions on all aspects of hand surgery, including peripheral nerve repair. As part of our strategy to expand the global reach of Remplir™, Phillip Edmondson, Vice President of Commercialization USA, and Gregor Maier, Vice President of Global Commercialization & Professional Engagements, attended the meeting alongside our UK distribution partner LEDA Orthopaedics (@LEDAortho). Two presentations discussed the use of Remplir at the meeting: Dr Michael Doarn presented a case series on revision carpal tunnel decompression using a collagen epineurial substitute; and Dr David Gamble presented on the management of neuromas with nerve capping. #Orthocell #BSSH #handsurgery #peripheralnerve #NerveRepair #Edinburgh #medtech
70
Earlier this week Orthocell sponsored and presented at the Peripheral Nerve Task Force dinner seminar during the 76th Congress of Neurological Surgeons (@CNS_Update) Annual Meeting in Washington, D.C. Orthocell's Senior Manager of Medical and Clinical Affairs (U.S. & Canada) Amber Muehlmann presented information and research on Remplir™, an epineurial substitute for surgeons attending the meeting. #2026CNS #Neurosurgery #PeripheralNerveSurgery #Orthocell #surgicaleducation
2
101
Thai and Australian surgeons met in Bangkok for the Thailand-Australia Nerve Repair Forum, hosted by @MeditimeThailand with @devicetech. The program included hospital visits at Siriraj and Ramathibodi, Remplir™ demonstrations and clinical case discussions on peripheral nerve repair. #Orthocell #Remplir #NerveRepair
3
110
Reminder: Orthocell 2026 AGM is this Friday, 6 Nov, 10.00am AWST (1.00pm AEDT). In person: The University Club of Western Australia Online: investor.automic.com.au Notice: bit.ly/4BIA2XU $OCC
94
The roll-out of Remplir™ in Thailand continues with the Thailand-Australia Nerve Repair Forum in Bangkok, hosted by @devicetech’s Thai distributor Meditime.  Tuesday, Nov 3 | 6–9 PM | Kimpton Maa-Lai. #Orthocell #Remplir #NerveRepair
1
68
ASX:OCC | Our strategic partner, Marine Biomedical, has received U.S. FDA 510(k) clearance for PearlBone™ - a bone graft substitute developed from sustainably sourced pearl shell from Western Australia's Kimberley region. ASX release: bit.ly/OCC_PearlBoneFDAClear… $OCC #Orthocell #regenerativemedicine #bonerepair #orthopaedics #invest
2
128
Orthocell (ASX:OCC) has recorded its strongest month of U.S. Remplir™ sales since launch: 92 units in October, generating approx. A$279,000 in revenue. bit.ly/OCCRemplirSalesNov26 $OCC #NerveRepair #ASX
1
3
199
Save the date: "From nerve repair to nerve regeneration," the Orthocell lunch symposium at #AAHS2027. Friday, January 29, 12:30–2:00 PM ET, Aventura, FL. Reserve your seat: handsurgery.org/forms/2027/S… #Orthocell #HandSurgery #PeripheralNerve
71
@OrthocellLtd CSO Prof. Ming Hao Zheng will deliver an invited keynote at #TERMISAP2026 in Christchurch, 27–30 Oct: “Neural tissue engineering for nerve and dura repair”. ap2026.termis.org/ #TissueEngineering
1
81
Paul Anderson will deliver a keynote address at the Festival of Innovation and Improvement tomorrow, Friday 23 October, at 9.15 am in Perth. In-person places are now full, but you can still register to attend the online event.
1
179
Watch now: Orthocell quarterly webinar CEO and MD Paul Anderson, CFO Jim Piper and CCO Adam Wood walked through the quarter and the company’s progress. See it here: bit.ly/4dT8jcQ $OCC #Orthocell #HealthInnovation #ASX
1
118
Orthocell Ltd retweeted
Host Tylah Tully sits down with @OrthocellLtd managing director and CEO Paul Anderson to discuss promising early results for Remplir in prostate cancer surgery, with 80% of patients recovering urinary continence. #ASX #MedTech $OCC buff.ly/VEPIX5Q
1
1
630
Thurs 22 Oct 11:00 am AEDT: @OrthocellLtd quarterly update webinar. Hear from CEO Paul Anderson, CFO Jim Piper and CCO Adam Wood. Register: bit.ly/47vQMnm $OCC #Orthocell #HealthInnovation #ASX
1
2
232